Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.81−0.08 (-2.77%)
Close on Nov 13, 2026Market cap $118.37MP/E –Yield –
Apyx Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Apyx Medical's operating cash flow for the twelve months ending Sep 30, 2026 was -$8.23M. For fiscal 2025 it was -$8.00M. The highest annual figure on record is $1.90M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.00M | – |
| FY2024 | Dec 31, 2024 | -$18.05M | – |
| FY2023 | Dec 31, 2023 | -$5.25M | – |
| FY2022 | Dec 31, 2022 | -$20.28M | – |
| FY2021 | Dec 31, 2021 | -$10.45M | – |
| FY2020 | Dec 31, 2020 | -$16.07M | – |
| FY2019 | Dec 31, 2019 | -$18.48M | – |
| FY2018 | Dec 31, 2018 | -$20.88M | – |
| FY2017 | Dec 31, 2017 | -$3.70M | – |
| FY2016 | Dec 31, 2016 | -$2.84M | – |
| FY2015 | Dec 31, 2015 | -$5.79M | – |
| FY2014 | Dec 31, 2014 | -$417.00K | – |
| FY2013 | Dec 31, 2013 | -$2.54M | -1637.0% |
| FY2012 | Dec 31, 2012 | $165.00K | -91.3% |
| FY2011 | Dec 31, 2011 | $1.90M | – |
| FY2010 | Dec 31, 2010 | -$526.00K | – |
| FY2009 | Dec 31, 2009 | -$97.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.63M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.49M | – |
| Q1 FY2026 | Mar 31, 2026 | -$572.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.54M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$702.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.44M | -220.1% |
| Q2 FY2024 | Jun 30, 2024 | -$4.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.34M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.21M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.70M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.85M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.53M | -2216.8% |
| Q3 FY2022 | Sep 30, 2022 | -$5.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.52M | – |
| Q4 FY2021 | Dec 31, 2021 | $214.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.61M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.01M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.05M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.02M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.41M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.25M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.55M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.59M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.09M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.05M | -2568.7% |
| Q3 FY2018 | Sep 30, 2018 | -$1.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$573.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.11M | – |
| Q4 FY2017 | Dec 31, 2017 | $731.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$541.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.08M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.82M | – |
| Q4 FY2016 | Dec 31, 2016 | -$544.00K | – |
See a number that looks wrong?